A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis
Cristina Regueiro, Luis Rodríguez‐Rodríguez, Raquel López‐Mejías, Laura Nuño, Ana Triguero‐Martínez, Eva Pérez‐Pampín, Alfonso Corrales, Alejandro Villalba, Y. Lopez-Golan, Lydia Abásolo, Sara Remuzgo‐Martínez, Ana M. Ortiz, Eva Herranz, Ana Martínez‐Feito, Carmen Conde, Antonio Mera, Alejandro Balsa, Isidoro González‐Álvaro, Miguel Á. González‐Gay, Benjamín Fernández‐Gutiérrez, Antonio González
Abstract
Abstract The major environmental risk factor for rheumatoid arthritis (RA) is smoking, which according to a widely accepted model induces protein citrullination in the lungs, triggering the production of anti-citrullinated protein antibodies (ACPA) and RA development. Nevertheless, some research findings do not fit this model. Therefore, we obtained six independent cohorts with 2253 RA patients for a detailed analysis of the association between smoking and RA autoantibodies. Our results showed a predominant association of smoking with the concurrent presence of the three antibodies: rheumatoid factor (RF), ACPA and anti-carbamylated protein antibodies (ACarPA) (3 Ab vs . 0 Ab: OR = 1.99, p = 2.5 × 10 –8 ). Meta-analysis with previous data (4491 patients) confirmed the predominant association with the concurrent presence of the three antibodies (3 Ab vs . 0 Ab: OR = 2.00, p = 4.4 ×10 –16 ) and revealed that smoking was exclusively associated with the presence of RF in patients with one or two antibodies (RF + 1+2 vs . RF − 0+1+2 : OR = 1.32, p = 0.0002). In contrast, no specific association with ACPA or ACarPA was found. Therefore, these results showed the need to understand how smoking favors the concordance of RA specific antibodies and RF triggering, perhaps involving smoking-induced epitope spreading and other hypothesized mechanisms.